Marina Beraza-Millor

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Hypertrophic Cardiomyopathy

Top Venues

Drug delivery and translational research

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease. Pharmaceutics 15 (7) (2023)
Julen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease. Nanomaterials (Basel, Switzerland) 12 (14) (2022)